Skip to main content
. 2018 Dec 18;13(12):e0209408. doi: 10.1371/journal.pone.0209408

Fig 6. Methylation of dCas9-MC/MN and associated variants as assessed by FspI restriction protection assay.

Fig 6

sgRNA1 was used to target methylation to site 1. Methylation was assayed from plasmid DNA extracted from ER2267 cells expressing the dCas9-MC/MN (WT) or the indicated dCas9-MC/MN variant. The first row indicates the position mutated, and the second row indicates the mutation made. The PFCSY set of mutations is in the final lane.